China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $6 | $6 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$5 | -$5 | -$0 | $0 |
| Revenue | $4 | $5 | $1 | $0 |
| % Growth | -16.4% | 668% | 18% | – |
| Gross Profit | $3 | $3 | $0 | $0 |
| % Margin | 75% | 75.1% | 74.4% | 74.8% |
| EBITDA | $1 | $1 | $0 | $0 |
| % Margin | 32.3% | 27.7% | 24.7% | 24.4% |
| Net Income | $1 | $0 | $0 | $0 |
| % Margin | 22.2% | 3% | 18.3% | 17.3% |
| EPS Diluted | 1.11 | 0.18 | 0.14 | 0.11 |
| % Growth | 516.7% | 28.6% | 27.3% | – |
| Operating Cash Flow | $1 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $0 | $0 | $0 |